USE OF A SEQUENTIAL PHOTONIC TRANSFER PROCEDURE TO PROMOTE SKIN PHOTOPROTECTION AND REGENERATION (Machine-translation by Google Translate, not legally binding)
The present invention falls within the field of biotechnology and refers to the use of a sequential photonic transfer procedure, based on compositions that combine organic compounds capable of absorbing ultraviolet (UV) sunlight to convert it into red light, promoting photoprotection against to sola...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
20.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention falls within the field of biotechnology and refers to the use of a sequential photonic transfer procedure, based on compositions that combine organic compounds capable of absorbing ultraviolet (UV) sunlight to convert it into red light, promoting photoprotection against to solar radiation and broad-spectrum skin regeneration. The photoprotective effect is due to the compounds in these compositions capable of absorbing UV light, while the regenerative effect is due to the final emission of red light from the combination of compounds, which, finally, activates a temporary production of non-lethal levels of reactive oxygen species (ROS) sufficient to stimulate homeostasis and regeneration programs. (Machine-translation by Google Translate, not legally binding)
La presente invención se encuadra en el ámbito de la biotecnología y se refiere al uso de un procedimiento de transferencia fotónica secuencial, basado en composiciones que combinan compuestos orgánicos capaces de absorber luz solar ultravioleta (UV) para convertirla en luz roja, fomentando la fotoprotección frente a la radiación solar y la regeneración cutánea de amplio espectro. El efecto fotoprotector se debe a los compuestos de estas composiciones capaces de absorber luz UV, mientras que el efecto regenerador se debe a la emisión final de luz roja de la combinación de compuestos, que, por último, activa en el tejido una producción transitoria de niveles no letales de especies reactivas de oxígeno (Reactive Oxygen Species; ROS) suficiente para estimular los programas de homeostasis y regeneración del mismo. |
---|---|
Bibliography: | Application Number: ES20220030422 |